President Donald Trump’s economic approval rating has fallen to the lowest point of either of his two terms, according to the latest CNBC All-America Economic Survey. Eight out of ten Americans now
HDA’s Kala Shankle is addressing one of the most pressing open questions in pharmaceutical distribution: what national licensure will mean for wholesalers and third-party logistics providers. Shankle, speaking to the biggest unresolved
More
China’s Top Court Orders RMB 800,000 Payout To Biosimilar Patent Inventor In Landmark Profit-Sharing Ruling China’s Supreme People’s Court has issued a significant final judgment clarifying how employers must calculate and pay
More
Next (NXT) has lifted its full-year profit forecast for the fourth time in 2026, crediting an “unexpected” boost from unusually warm summer weather across the UK. The FTSE 100 retailer raised its
More
The Bank of England is widely expected to leave its 3.75% Bank Rate unchanged on Thursday, even as inflation climbs well above its 2% target. Markets are pricing in more than an
More
The bosses of the world’s most powerful artificial intelligence companies are calling for regulation and a slower pace of development, raising eyebrows across the business world. Anthropic’s Dario Amodei and OpenAI’s Sam
More
DHL has broken ground on a new cold chain hub at Singapore’s Changi Airport, marking a significant expansion of its pharmaceutical logistics capabilities in Asia. The new facility underlines growing demand for
More
The US Securities and Exchange Commission is proposing a sweeping overhaul of the securities transfer agent regulatory framework, which has largely remained unchanged since the mid-1970s. The existing rules were built around
More
The FTSE 100 opened higher on 16 September 2026, climbing 0.38 per cent to 10,697.83 as investors awaited the Federal Reserve’s interest-rate decision. European markets followed suit, with the Euronext 100 rising
More
FTSE 100 And FTSE 250 Rise As London Markets Strengthen Ahead Of Fed Rate Decision London’s leading indices pushed higher on Wednesday as investors positioned themselves cautiously ahead of a closely watched
More
Vera Therapeutics (NASDAQ: VERA) has reported promising new phase 3 clinical data showing its treatment Trutakna successfully stabilises kidney function in patients with IgA nephropathy. The results represent a significant milestone for
More